Matinas BioPharma Holdings (MTNB) Assets (2013 - 2026)
Matinas BioPharma Holdings (MTNB) recorded Assets of $3.41 million in Q2 2026, down 70.1% from $11.42 million a year earlier and down 41.9% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings reported Assets of $7.21 million, down 43.0% from FY2024.
- Annual Assets has declined for five straight years, with a five-year compound annual growth rate of -36.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $12.64 million in FY2024 (-49.6%), $25.1 million in FY2023 (-44.0%), $44.82 million in FY2022 (-26.9%) and $61.33 million in FY2021 (-13.6%).
- The Q2 2026 figure is the lowest quarterly Assets since Q4 2014.
- On a year-over-year basis, Assets has declined for 22 consecutive quarters, with an average decline of 48.7% over the last eight quarters.
- Across the past five years, year-over-year decline in Assets ran from 10.5% in Q3 2021 to 70.1% in Q2 2026.
- Per Business Quant, the preceding three quarters came in at $5.87 million (Q1 2026), $7.21 million (Q4 2025) and $9.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | 3.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.41 Mn |
| Mar 31, 2026 | 5.87 Mn |
| Dec 31, 2025 | 7.21 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 11.42 Mn |
| Mar 31, 2025 | 12.04 Mn |
| Dec 31, 2024 | 12.64 Mn |
| Sep 30, 2024 | 20.58 Mn |
| Jun 30, 2024 | 24.37 Mn |
| Mar 31, 2024 | 19.61 Mn |
| Dec 31, 2023 | 25.10 Mn |
| Sep 30, 2023 | 29.79 Mn |
| Jun 30, 2023 | 34.03 Mn |
| Mar 31, 2023 | 38.26 Mn |
| Dec 31, 2022 | 44.82 Mn |
| Sep 30, 2022 | 47.55 Mn |
| Jun 30, 2022 | 52.42 Mn |
| Mar 31, 2022 | 55.78 Mn |
| Dec 31, 2021 | 61.33 Mn |
| Sep 30, 2021 | 66.98 Mn |
API Access
Matinas BioPharma Holdings Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();